---
layout: minimal-medicine
title: Romiplostim
---

# Romiplostim
### Generic Name
Romiplostim

### Usage
Romiplostim is a medication used to treat thrombocytopenia (low platelet count) in adults and children with chronic immune thrombocytopenic purpura (ITP).  ITP is a condition where the immune system mistakenly attacks and destroys platelets, leading to an increased risk of bleeding. Romiplostim is specifically indicated for patients who haven't responded adequately to other treatments like corticosteroids, immunoglobulins, or splenectomy.  It's crucial to understand that Romiplostim is only used when the low platelet count poses a significant bleeding risk.  It's not suitable for treating thrombocytopenia caused by myelodysplastic syndrome or other conditions besides ITP.

### Dosage

**Adults with ITP:** Romiplostim is administered subcutaneously (under the skin). The initial dose is typically 1 mcg/kg of body weight once weekly.  The dose is adjusted in increments of 1 mcg/kg/week, aiming for a platelet count of at least 50,000/mm³. The goal is to manage bleeding risk, not to normalize platelet counts. The maximum weekly dose is 10 mcg/kg.  Dosage adjustments are based on platelet count response;  if the count is too low, the dose is increased; if it's too high, the dose is reduced or withheld.  Treatment is discontinued if there's no improvement in platelet count after four weeks at the maximum dose.

**Children and Adolescents with ITP:** The initial dose is also 1 mcg/kg subcutaneously once weekly.  Similar to adults, adjustments are made in 1 mcg/kg increments to achieve a platelet count of at least 50,000/mm³,  again focusing on bleeding risk management.  The maximum dose remains 10 mcg/kg weekly. Body weight should be reassessed every 12 weeks.

**Dosage Adjustments:**  No specific dosage adjustments are recommended for patients with hepatic (liver) or renal (kidney) impairment, but caution is advised in these cases.  Specific adjustments based on platelet count response are outlined in the adult and pediatric sections above.

### Side Effects

**Common Side Effects:**

* Headache
* Dizziness
* Insomnia
* Diarrhea
* Upper abdominal pain
* Abdominal pain
* Skin rash
* Bruising
* Arthralgia (joint pain)
* Myalgia (muscle pain)
* Limb pain
* Upper respiratory tract infection
* Oropharyngeal pain (pain in the mouth and throat)
* Fever


**Less Common, but Serious Side Effects:**

* Myelodysplastic syndromes (MDS) progression to acute myeloid leukemia (AML)
* Myelofibrosis (bone marrow scarring)
* Portal vein thrombosis (blood clot in the portal vein)
* Thrombotic/thromboembolic complications (blood clots)
* Worsening thrombocytopenia after stopping Romiplostim
* Loss of response to Romiplostim
* Allergic reactions (angioedema, hypersensitivity)


If you experience any side effects, especially those listed as serious, consult your doctor immediately.

### How it Works

Romiplostim is a thrombopoietin (TPO) receptor agonist.  Thrombopoietin is a hormone that stimulates the production of platelets in the bone marrow. Romiplostim mimics the action of TPO, binding to and activating its receptor on megakaryocytes (cells that produce platelets), leading to increased platelet production and consequently, a higher platelet count.

### Precautions

**Contraindications:** Romiplostim is contraindicated in patients with hypersensitivity to Romiplostim or any of its components, or those with a history of sensitivity to Escherichia coli-derived products (as it's produced using E. coli).

**Warnings and Precautions:**  There's an increased risk of bone marrow fibrosis, progression of MDS to AML, portal vein thrombosis (especially in patients with chronic liver disease), thrombotic/thromboembolic complications, and worsening thrombocytopenia after stopping treatment.  Caution is advised in patients with renal or hepatic impairment. Patients should be monitored closely for these risks.

**Pregnancy and Lactation:** Romiplostim is categorized as Pregnancy Category C.  It may harm the fetus. Breastfeeding is not recommended during Romiplostim treatment.


### FAQs

**Q: How is Romiplostim administered?**
A: Romiplostim is given as a subcutaneous injection.

**Q: How long does it take to see results?**
A:  The time to see an increase in platelet count varies, but improvement may be seen within a few weeks of starting treatment.

**Q: What should I do if I miss a dose?**
A:  Contact your doctor immediately to discuss how to proceed.  Do not double the next dose.

**Q: How should I store Romiplostim?**
A: Follow the storage instructions provided with your medication.

**Q: Are there any interactions with other medications?**
A: While no significant interactions are specifically listed, it's essential to inform your doctor about all medications you are taking, including over-the-counter drugs and supplements.

**Q:  What should I do if I experience side effects?**
A: Report any side effects, particularly serious ones, to your doctor promptly.


**Disclaimer:** This information is intended for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider for diagnosis and treatment of any medical condition.  The information provided here is not exhaustive and may not reflect the most current updates to the drug information. Always refer to the official prescribing information for complete and up-to-date details.
